Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype

Tatiana L Fonseca1, Vanda Jorgetti, Cristiane C Costa

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Insights

Sympathetic nervous system (SNS) hyperactivity, caused by knocking out negative regulators of norepinephrine release (alpha-2A/2C-adrenoceptor knockout mice), unexpectedly increases bone mass. This suggests alpha-2-adrenoceptors play a role in SNS regulation of bone.

Area of Science:

  • Skeletal Biology
  • Neuroendocrinology
  • Pharmacology

Background:

  • Sympathetic nervous system (SNS) activation is known to cause osteopenia through beta(2)-adrenoceptor (β2-AR) signaling.
  • The specific role of other adrenoceptors in regulating bone turnover remains less understood.

Purpose of the Study:

  • To investigate the skeletal effects of chronic sympathetic hyperactivity resulting from the absence of negative adrenergic feedback.
  • To determine the involvement of alpha-2 adrenoceptors (α(2)-ARs) in sympathetic regulation of bone mass.

Main Methods:

  • Generation and analysis of female α(2A)/α(2C)-adrenoceptor knockout (α(2A)/α(2C)-ARKO) mice exhibiting chronic sympathetic hyperactivity.
  • Micro-computed tomography (µCT) and biomechanical testing to assess bone structure and strength.
  • Quantitative real-time PCR (qPCR) and immunohistochemistry to analyze adrenoceptor expression and bone-related factors in bone tissue and cells.
  • In vitro studies on isolated osteoclasts to assess their response to adrenoceptor agonists and antagonists.

Main Results:

  • α(2A)/α(2C)-ARKO mice displayed a high bone mass phenotype with significantly increased trabecular bone volume, connectivity, and cortical thickness compared to wild-type (WT) mice.
  • Bone resorption markers (TRACP, RANK) were reduced in KO mice, while bone formation appeared increased.
  • Expression of α(2A)-, α(2B)-, and α(2C)-ARs was detected in bone cells (osteoblasts, osteoclasts, chondrocytes), and isolated osteoclasts responded to α(2)-AR modulation.
  • β(2)-AR mRNA levels were similar between KO and WT mice, indicating other adrenoceptors contribute to SNS effects on bone.

Conclusions:

  • Chronic sympathetic hyperactivity, mediated by the absence of α(2)-AR negative feedback, leads to increased bone mass, challenging the sole role of β(2)-AR signaling.
  • α(2)-ARs are expressed in bone cells and can modulate osteoclast activity, suggesting they are key mediators of sympathetic nervous system actions on the skeleton.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...